Ac-DHLASLWWGTEL-NH2

Ref. 3D-PP45457

Informação sobre produto

• Nome: Ac-DHLASLWWGTEL-NH2
• Sinónimos: Ac-Asp-His-Leu-Ala-Ser-Leu-Trp-Trp-Gly-Thr-Glu-Leu-amide

Descrição

Peptide Ac-DHLASLWWGTEL-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-DHLASLWWGTEL-NH2 include the following: Glypican-3 (GPC-3) for early diagnosis and target therapy Y Li - J Clin Images Med Case Rep, 2023 - jcimcr.orghttps://jcimcr.org/pdfs/JCIMCR-v4-2321.pdf Smart glypican-3-targeting peptide-chlorin e6 conjugates for targeted photodynamic therapy of hepatocellular carcinoma Y Fang, H Ma, X Zhang, P Zhang, Y Li, S He - European Journal of , 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0223523423010140 Imaging ligands targeting glypican-3 receptor expression in hepatocellular carcinoma SD Grega , DX Zheng , QH Zheng - American Journal of Nuclear , 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441927/ Trials in developing a nanoscale material for extravascular contrast-enhanced ultrasound targeting hepatocellular carcinoma S Wu, X Lin - PeerJ, 2020 - peerj.comhttps://peerj.com/articles/10403/ In Vitro Performance of Published Glypican 3-Targeting Peptides TJ12P1 and L5 Indicates Lack of Specificity and Potency RM Berman, OJ Kelada , NT Gutsche - Cancer Biotherapy & , 2019 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/cbr.2019.2888 In vivo imaging of hepatocellular carcinoma using a glypican-3-binding peptide based probe Q Zhang, Z Han, W Zhang, Z Qian - , and Molecular Probes , 2017 - spiedigitallibrary.orghttps://www.spiedigitallibrary.org/conference-proceedings-of-spie/10079/100790T/In-vivo-imaging-of-hepatocellular-carcinoma-using-a-glypican-3/10.1117/12.2251310.short An innovative peptide with high affinity to GPC3 for hepatocellular carcinoma diagnosis Q Zhang, Z Han, J Tao, M Zhao, W Zhang, P Li - Biomaterials , 2019 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2019/bm/c8bm01016a Novel nanotechnology approaches to overcome drug resistance in the treatment of hepatocellular carcinoma: glypican 3 as a useful target for innovative therapies M Mossenta, D Busato, M Dal Bo, P Macor - International Journal of , 2022 - mdpi.comhttps://www.mdpi.com/1422-0067/23/17/10038 Biology and function of glypican-3 as a candidate for early cancerous transformation of hepatocytes in hepatocellular carcinoma M Montalbano , J Georgiadis - Oncology , 2017 - spandidos-publications.comhttps://www.spandidos-publications.com/10.3892/or.2017.5387?text=fulltext Small-molecule fluorescence-based probes for interrogating major organ diseases HH Han , H Tian , Y Zang, AC Sedgwick , J Li - Chemical Society , 2021 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2021/cs/d0cs01183e Targeted and multifunctional technology for identification between hepatocellular carcinoma and liver cirrhosis H Deng, W Shang , G Lu, P Guo, T Ai - ACS applied materials , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsami.8b20600 Novel glypican-3-binding peptide for in vivo hepatocellular carcinoma fluorescent imaging D Zhu, Y Qin, J Wang , L Zhang , S Zou - Bioconjugate , 2016 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.bioconjchem.6b00030

• Marca: Biosynth